$RGNX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENXBIO Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENXBIO Inc.. Get notifications about new insider transactions in REGENXBIO Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2021 | RGNX | REGENXBIO Inc. | Fox Allan M. | Option Exercise | A | 35.52 | 10,000 | 355,200 | 10,000 | ||
Feb 17 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 4,701 | 56,882 | 6,430 | |
Feb 17 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.08 | 4,701 | 230,725 | 16,372 | 21.1 K to 16.4 K (-22.31 %) |
Feb 17 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 4,701 | 56,882 | 21,073 | 16.4 K to 21.1 K (+28.71 %) |
Feb 10 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 1,300 | 15,730 | 11,131 | |
Feb 10 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.11 | 1,300 | 63,843 | 16,372 | 17.7 K to 16.4 K (-7.36 %) |
Feb 10 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 1,300 | 15,730 | 17,672 | 16.4 K to 17.7 K (+7.94 %) |
Feb 04 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 10,000 | 121,000 | 12,431 | |
Feb 04 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 45.13 | 500 | 22,565 | 16,372 | 16.9 K to 16.4 K (-2.96 %) |
Feb 04 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 44.77 | 9,500 | 425,315 | 16,872 | 26.4 K to 16.9 K (-36.02 %) |
Feb 04 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 10,000 | 121,000 | 26,372 | 16.4 K to 26.4 K (+61.08 %) |
Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 6,500 | 5,525 | 41,170 | |
Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 44.99 | 5,211 | 234,443 | 280,984 | 286.2 K to 281 K (-1.82 %) |
Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 44.05 | 974 | 42,905 | 286,195 | 287.2 K to 286.2 K (-0.34 %) |
Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 42.64 | 315 | 13,432 | 287,169 | 287.5 K to 287.2 K (-0.11 %) |
Jan 27 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 6,500 | 5,525 | 287,484 | 281 K to 287.5 K (+2.31 %) |
Jan 20 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.04 | 252 | 12,610 | 113,640 | 113.9 K to 113.6 K (-0.22 %) |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 35.80 | 10,372 | 371,318 | 17,128 | |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 19.50 | 1,240 | 24,180 | 0 | |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 19.50 | 1,700 | 33,150 | 1,240 | |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Sell | S | 50.01 | 11,612 | 580,716 | 17,748 | 29.4 K to 17.7 K (-39.55 %) |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 35.80 | 10,372 | 371,318 | 29,360 | 19 K to 29.4 K (+54.62 %) |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 19.50 | 1,240 | 24,180 | 18,988 | 17.7 K to 19 K (+6.99 %) |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Sell | S | 50.03 | 1,700 | 85,051 | 17,748 | 19.4 K to 17.7 K (-8.74 %) |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 19.50 | 1,700 | 33,150 | 19,448 | 17.7 K to 19.4 K (+9.58 %) |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.03 | 11,093 | 554,983 | 113,892 | 125 K to 113.9 K (-8.88 %) |
Jan 14 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.01 | 4,200 | 210,042 | 124,985 | 129.2 K to 125 K (-3.25 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 19.50 | 1,378 | 26,871 | 641 | |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 19.50 | 2,622 | 51,129 | 2,019 | |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 7,500 | 90,750 | 22,431 | |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 10,000 | 121,000 | 29,931 | |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.15 | 1,378 | 67,729 | 16,372 | 17.8 K to 16.4 K (-7.76 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 19.50 | 1,378 | 26,871 | 17,750 | 16.4 K to 17.8 K (+8.42 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.08 | 10,122 | 496,788 | 16,372 | 26.5 K to 16.4 K (-38.20 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 19.50 | 2,622 | 51,129 | 26,494 | 23.9 K to 26.5 K (+10.98 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 7,500 | 90,750 | 23,872 | 16.4 K to 23.9 K (+45.81 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 48.13 | 1,320 | 63,532 | 16,372 | 17.7 K to 16.4 K (-7.46 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 47.42 | 4,062 | 192,620 | 17,692 | 21.8 K to 17.7 K (-18.67 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 46.43 | 4,618 | 214,414 | 21,754 | 26.4 K to 21.8 K (-17.51 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 10,000 | 121,000 | 26,372 | 16.4 K to 26.4 K (+61.08 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 19.50 | 1,378 | 26,871 | 641 | |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 19.50 | 2,622 | 51,129 | 2,019 | |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 7,500 | 90,750 | 22,431 | |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | M | 12.10 | 10,000 | 121,000 | 29,931 | |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.15 | 1,378 | 67,729 | 16,372 | 17.8 K to 16.4 K (-7.76 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 19.50 | 1,378 | 26,871 | 17,750 | 16.4 K to 17.8 K (+8.42 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 49.08 | 10,122 | 496,788 | 16,372 | 26.5 K to 16.4 K (-38.20 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 19.50 | 2,622 | 51,129 | 26,494 | 23.9 K to 26.5 K (+10.98 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 7,500 | 90,750 | 23,872 | 16.4 K to 23.9 K (+45.81 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 48.13 | 1,320 | 63,532 | 16,372 | 17.7 K to 16.4 K (-7.46 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 47.42 | 4,062 | 192,620 | 17,692 | 21.8 K to 17.7 K (-18.67 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Sell | S | 46.43 | 4,618 | 214,414 | 21,754 | 26.4 K to 21.8 K (-17.51 %) |
Jan 12 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Buy | M | 12.10 | 10,000 | 121,000 | 26,372 | 16.4 K to 26.4 K (+61.08 %) |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | M | 19.50 | 5,185 | 101,108 | 2,940 | |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Sell | S | 50.01 | 5,185 | 259,302 | 17,748 | 22.9 K to 17.7 K (-22.61 %) |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Buy | M | 19.50 | 5,185 | 101,108 | 22,933 | 17.7 K to 22.9 K (+29.21 %) |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 48.15 | 573 | 27,590 | 129,185 | 129.8 K to 129.2 K (-0.44 %) |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 47.49 | 2,208 | 104,858 | 129,758 | 132 K to 129.8 K (-1.67 %) |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 46.45 | 2,460 | 114,267 | 131,966 | 134.4 K to 132 K (-1.83 %) |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.00 | 10,998 | 549,900 | 134,426 | 145.4 K to 134.4 K (-7.56 %) |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 1,500 | 1,275 | 47,670 | |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 50.01 | 1,500 | 75,015 | 281,984 | 283.5 K to 282 K (-0.53 %) |
Jan 11 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 1,500 | 1,275 | 283,484 | 282 K to 283.5 K (+0.53 %) |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | A | 44.97 | 56,200 | 2,527,314 | 56,200 | |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Grant | A | 0.00 | 12,400 | 0 | 145,424 | 133 K to 145.4 K (+9.32 %) |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Option Exercise | A | 44.97 | 62,300 | 2,801,631 | 62,300 | |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper. & Tech. ... | Grant | A | 0.00 | 13,800 | 0 | 17,748 | 3.9 K to 17.7 K (+349.54 %) |
Jan 06 2021 | RGNX | REGENXBIO Inc. | PAKOLA STEVE | Chief Medical Offic ... | Option Exercise | A | 44.97 | 49,700 | 2,235,009 | 49,700 | |
Jan 06 2021 | RGNX | REGENXBIO Inc. | PAKOLA STEVE | Chief Medical Offic ... | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 44.97 | 52,500 | 2,360,925 | 52,500 | |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Grant | A | 0.00 | 11,600 | 0 | 19,043 | 7.4 K to 19 K (+155.85 %) |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Grant | A | 31.31 | 641 | 20,067 | 7,443 | 6.8 K to 7.4 K (+9.42 %) |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Grant | A | 34.82 | 302 | 10,517 | 6,802 | 6.5 K to 6.8 K (+4.65 %) |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Option Exercise | A | 44.97 | 62,500 | 2,810,625 | 62,500 | |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | Chief Legal Officer | Grant | A | 0.00 | 13,800 | 0 | 16,372 | 2.6 K to 16.4 K (+536.55 %) |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | A | 44.97 | 185,167 | 8,326,960 | 185,167 | |
Jan 06 2021 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Grant | A | 0.00 | 40,984 | 0 | 281,984 | 241 K to 282 K (+17.01 %) |
Dec 30 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 6,500 | 5,525 | 49,170 | |
Dec 30 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 49.16 | 1,853 | 91,093 | 241,000 | 242.9 K to 241 K (-0.76 %) |
Dec 30 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 48.47 | 4,647 | 225,240 | 242,853 | 247.5 K to 242.9 K (-1.88 %) |
Dec 30 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 6,500 | 5,525 | 247,500 | 241 K to 247.5 K (+2.70 %) |
Dec 28 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.00 | 3,376 | 168,800 | 133,024 | 136.4 K to 133 K (-2.48 %) |
Dec 28 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.01 | 21,124 | 1,056,411 | 136,400 | 157.5 K to 136.4 K (-13.41 %) |
Dec 28 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 4,500 | 3,825 | 55,670 | |
Dec 28 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 50.00 | 4,500 | 225,000 | 241,000 | 245.5 K to 241 K (-1.83 %) |
Dec 28 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 4,500 | 3,825 | 245,500 | 241 K to 245.5 K (+1.87 %) |
Dec 18 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 15,000 | 12,750 | 60,170 | |
Dec 18 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 45.00 | 15,000 | 675,000 | 241,000 | 256 K to 241 K (-5.86 %) |
Dec 18 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 15,000 | 12,750 | 256,000 | 241 K to 256 K (+6.22 %) |
Dec 14 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 40.17 | 14,916 | 599,176 | 157,524 | 172.4 K to 157.5 K (-8.65 %) |
Dec 14 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 40.06 | 22,584 | 904,715 | 172,440 | 195 K to 172.4 K (-11.58 %) |
Dec 14 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 4,500 | 3,825 | 75,170 | |
Dec 14 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 40.00 | 4,500 | 180,000 | 241,000 | 245.5 K to 241 K (-1.83 %) |
Dec 14 2020 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 4,500 | 3,825 | 245,500 | 241 K to 245.5 K (+1.87 %) |
Sep 18 2020 | RGNX | REGENXBIO Inc. | Fox Allan M. | Director | Gift | G | 0.00 | 90,000 | 0 | 315,000 | 225 K to 315 K (+40.00 %) |
Sep 18 2020 | RGNX | REGENXBIO Inc. | Fox Allan M. | Director | Gift | G | 0.00 | 90,000 | 0 | 1,324,110 | 1.4 M to 1.3 M (-6.36 %) |
Sep 18 2020 | RGNX | REGENXBIO Inc. | Fox Allan M. | Director | Gift | G | 0.00 | 225,000 | 0 | 225,000 | 0 to 225 K |
Sep 18 2020 | RGNX | REGENXBIO Inc. | Fox Allan M. | Director | Gift | G | 0.00 | 225,000 | 0 | 1,414,110 | 1.6 M to 1.4 M (-13.73 %) |
Jul 17 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 13.09 | 3,259 | 42,660 | 14,115 | |
Jul 17 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 40.10 | 14,950 | 599,495 | 195,024 | 210 K to 195 K (-7.12 %) |
Jul 17 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 13.09 | 3,259 | 42,660 | 209,974 | 206.7 K to 210 K (+1.58 %) |
Jun 02 2020 | RGNX | REGENXBIO Inc. | Tasse Daniel | Option Exercise | A | 37.66 | 10,000 | 376,600 | 10,000 | ||
Jun 02 2020 | RGNX | REGENXBIO Inc. | STUMP DAVID C | Option Exercise | A | 37.66 | 10,000 | 376,600 | 10,000 | ||
Jun 02 2020 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Option Exercise | A | 37.66 | 10,000 | 376,600 | 10,000 | ||
Jun 02 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | A | 37.66 | 10,000 | 376,600 | 10,000 | ||
Jun 02 2020 | RGNX | REGENXBIO Inc. | Glucksmann Alexandra | Option Exercise | A | 37.66 | 10,000 | 376,600 | 10,000 | ||
Jun 02 2020 | RGNX | REGENXBIO Inc. | Fox Allan M. | Option Exercise | A | 37.66 | 10,000 | 376,600 | 10,000 | ||
May 12 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 13.09 | 500 | 6,545 | 17,374 | |
May 12 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 13.09 | 2,500 | 32,725 | 17,874 | |
May 12 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 40.00 | 500 | 20,000 | 206,715 | 207.2 K to 206.7 K (-0.24 %) |
May 12 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 13.09 | 500 | 6,545 | 207,215 | 206.7 K to 207.2 K (+0.24 %) |
May 12 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 40.18 | 7,000 | 281,260 | 206,715 | 213.7 K to 206.7 K (-3.28 %) |
May 12 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 13.09 | 2,500 | 32,725 | 213,715 | 211.2 K to 213.7 K (+1.18 %) |
Apr 02 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 0.85 | 10,000 | 8,500 | 74,900 | |
Apr 02 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 0.85 | 10,000 | 8,500 | 220,215 | 210.2 K to 220.2 K (+4.76 %) |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 6,633 | 145,926 | 0 | |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 19.50 | 4,253 | 82,934 | 8,125 | |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 14,928 | 328,416 | 6,633 | |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 12,479 | 446,748 | 27,500 | |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 51.37 | 3,692 | 189,658 | 3,948 | 7.6 K to 3.9 K (-48.32 %) |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.13 | 8,872 | 444,753 | 7,640 | 16.5 K to 7.6 K (-53.73 %) |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 6,633 | 145,926 | 16,512 | 9.9 K to 16.5 K (+67.14 %) |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.22 | 44,429 | 2,231,224 | 9,879 | 54.3 K to 9.9 K (-81.81 %) |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 12,479 | 446,748 | 54,308 | 41.8 K to 54.3 K (+29.83 %) |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 14,928 | 328,416 | 41,829 | 26.9 K to 41.8 K (+55.49 %) |
Feb 12 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 19.50 | 4,253 | 82,934 | 26,901 | 22.6 K to 26.9 K (+18.78 %) |
Feb 12 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 24,800 | 21,080 | 129,100 | ||
Feb 12 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.11 | 24,800 | 1,242,728 | 0 | 24.8 K to 0 (-100.00 %) | |
Feb 12 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 24,800 | 21,080 | 24,800 | 0 to 24.8 K | |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 13.09 | 2,708 | 35,448 | 0 | |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 19.50 | 1,000 | 19,500 | 12,378 | |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 958 | 21,076 | 21,561 | |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 471 | 16,862 | 39,979 | |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.00 | 5,637 | 281,850 | 22,648 | 28.3 K to 22.6 K (-19.93 %) |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 471 | 16,862 | 28,285 | 27.8 K to 28.3 K (+1.69 %) |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 958 | 21,076 | 27,814 | 26.9 K to 27.8 K (+3.57 %) |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 19.50 | 1,000 | 19,500 | 26,856 | 25.9 K to 26.9 K (+3.87 %) |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 13.09 | 2,708 | 35,448 | 25,856 | 23.1 K to 25.9 K (+11.70 %) |
Feb 07 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.00 | 300 | 15,000 | 222,021 | 222.3 K to 222 K (-0.13 %) |
Feb 07 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 2,000 | 1,700 | 153,900 | ||
Feb 07 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.00 | 2,000 | 100,000 | 0 | 2 K to 0 (-100.00 %) | |
Feb 07 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 2,000 | 1,700 | 2,000 | 0 to 2 K | |
Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 19.50 | 1,622 | 31,629 | 13,378 | |
Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 2,700 | 59,400 | 22,519 | |
Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 800 | 28,640 | 40,450 | |
Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.00 | 5,922 | 296,100 | 23,148 | 29.1 K to 23.1 K (-20.37 %) |
Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 800 | 28,640 | 29,070 | 28.3 K to 29.1 K (+2.83 %) |
Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 2,700 | 59,400 | 28,270 | 25.6 K to 28.3 K (+10.56 %) |
Jan 21 2020 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 19.50 | 1,622 | 31,629 | 25,570 | 23.9 K to 25.6 K (+6.77 %) |
Jan 21 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.00 | 2,394 | 119,700 | 222,321 | 224.7 K to 222.3 K (-1.07 %) |